Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    BERG Study Identifies a Genetic Factor Responsible For a Disproportionate Number of COVID-19 Cases Among African Americans

    PRNewswire recently carried BERG’s announcement of the results of its COVID-19 clinical study. BERG, a biotech company based in Framingham, Mass., utilizes artificial intelligence in its research of diseases and…

    Continue Reading BERG Study Identifies a Genetic Factor Responsible For a Disproportionate Number of COVID-19 Cases Among African Americans
    Study Identifies Predictive Tools to Shorten Active Surveillance Required in Prostate Cancer
    Source: Pixabay

    Study Identifies Predictive Tools to Shorten Active Surveillance Required in Prostate Cancer

    PracticeUpdate recently published an article relating to a study with the primary goal of lightening the burden that many males experience regarding long-term prostate surveillance. Active surveillance has been preferred…

    Continue Reading Study Identifies Predictive Tools to Shorten Active Surveillance Required in Prostate Cancer
     Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
    source: pixabay.com

     Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations

    Dr. Jasvinder Singh, a rheumatologist at Alabama’s University in Birmingham is the author of a study that was featured in Arthritis Care and Research. During a recent interview with MedPageToday,…

    Continue Reading  Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
    The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
    source: pixabay.com

    The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients

    Target RWE, an innovative health evidence solutions company based in Durham, North Carolina recently announced its current data from the study of nonalcoholic steatohepatitis (NASH) via PRNewswire. The study, entitled…

    Continue Reading The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
    Patients with Alpha-1 Antitrypsin Deficiency Liver Disease Show Improvement After Six Months of Experimental Treatment
    source: pixabay.com

    Patients with Alpha-1 Antitrypsin Deficiency Liver Disease Show Improvement After Six Months of Experimental Treatment

      Arrowhead Pharmaceuticals recently announced positive twenty-four-week biopsy results from four patients who participated in the first cohort of the Phase II clinical trial of ARO-AAT. ARO-AAT is Arrowhead’s investigational…

    Continue Reading Patients with Alpha-1 Antitrypsin Deficiency Liver Disease Show Improvement After Six Months of Experimental Treatment
    Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
    source: pixabay.com

    Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

      According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

    Continue Reading Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
    Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years
    source: pixabay.com

    Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years

      Dr. Richard Furie at New York’s Feinstein Institutes recently interviewed with MedPage Today. Dr. Furie discussed the prognosis for lupus nephritis and belimumab (Benlysta), a recently-tested drug that appears…

    Continue Reading Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years

    Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

    According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

    Continue Reading Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

    Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19

    Business Insider recently interviewed Marissa Oliver, a resident of New York City, who told us about the problems she has encountered during her recovery from COVID-19. Marissa, an arts manager,…

    Continue Reading Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19

    Early Stages of Precision Medicine Being Developed for Cancer Patients During the COVID-19 Pandemic

    A recent article in Med City News outlines the difficult choices patients must make regarding immune compromising but life-saving therapy during the 2020 pandemic. Do they postpone their treatment or…

    Continue Reading Early Stages of Precision Medicine Being Developed for Cancer Patients During the COVID-19 Pandemic